Wednesday, Apr 24 2024 | Time 00:35 Hrs(IST)
image
Business Economy


BioAsia announces 'Genome Valley Excellence Award' to Dr Carl, Dr Narasimhan

Hyderabad, Feb 12 (UNI) BioAsia, Asia's largest annual global Biotechnology and Life Sciences forum organized by the Government of Telangana, has announced that the prestigious 'Genome Valley Excellence Award' will be bestowed upon Dr Carl H June & Dr Vas Narasimhan.

The awards will be presented to them during the 17th edition of BioAsia which will be held from February 17 to 19 at HICC, Hyderabad, a statement here said on Wednesday.

Dr Carl H June is an American immunologist and Oncologist. He is the pioneer in the field of immunotherapy and globally acknowledged for the development of T-Cell Therapy for Cancer. His findings have helped to develop and commercialize the first FDA approved gene therapy called Tisagenlecleucel.
CAR-T Cell therapy, a form of immunotherapy that uses specially altered T-Cells (a part of the immune system) to fight cancer. A sample of patient’s T-Cells is collected from the blood and then modified to produce special structures called Chimeric Antigen Receptors (CARs) on their surface.
Dr June is Richard W Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine, University of Pennsylvania, USA.

Dr Vasant Narasimhan, popularly known as Vas Narasimhan, is the CEO of a global pharmaceutical company – Novartis. He is an Indian American Physician and has led a strategic and cultural transformation at Novartis to build a leading medicines company globally powered by advanced therapy platforms and data science.

Dr Narasimhan joined Novartis in 2005 and he served as the Global Head of Development before he assumed charge of CEO of the company in 2017.
He previously served as Global Head of Biopharmaceuticals and Oncology injectables at Sandoz International and was a member of the US National Academy of Medicine. With his ancestral roots at Tamil Nadu, Dr Narasimhan completed his graduation in biological sciences from University of Chicago and did his MD from Harvard Medical School.
He also completed his master’s degree in Public Policy from John F Kennedy School of Government, US.
MORE UNI VV CS 1634
More News
Sensex ends in green; up 89 83 points

Sensex ends in green; up 89 83 points

23 Apr 2024 | 6:58 PM

Mumbai, April 23 (UNI) The stock market on Tuesday opened strong with 400 points up with all-round shopping but paired early gains towards end of the trading hour and closed at 73,738, about 90 points up from its previous close.

see more..

FHRAI seeks govt intervention to utilize increased FAR scheme for hotel industry expansion

23 Apr 2024 | 6:55 PM

New Delhi, Apr 23 (UNI) The apex association of hotels and restaurants FHRAI has approached the Government for resolution of long pending issue of not able to use the provision of increased Floor Area Ratio (FAR) saying this coming in the way to expanding the capacity and new hotel developments in Delhi.

see more..

23 Apr 2024 | 6:22 PM

New Delhi, Apr 23 (UNI) Telecom major Jio Infocomm, a wholly owned by Reliance Industries Limited, has increased its subscriber tally to 470.86 million at the end of December, 2023, up 8.76 per cent from its subscriber base of 432.92 million a year ago.

see more..

Kottayam-Kochi Rubber Market Rates

23 Apr 2024 | 6:11 PM

Kottayam, April 23 (UNI) Following were the Rubber Market rates announced by the Rubber Board here today per quintal.

see more..

Rupee marginally up 3 paise against USD

23 Apr 2024 | 4:37 PM

Mumbai, April 23 (UNI) The Rupee on Tuesday gained three paise to close at 83.34 against the USD on selling US Dollar by bankers and exporters, dealers at the Foreign exchange said.

see more..
image